Hester Biosciences has informed that, as per Regulation 30 of the SEBI (Listing Obligations and Disclosure Requirements) Regulations, 2015, the Company has scheduled investor interaction through a teleconference call on Thursday, 30 January 2025 at 2:00 pm (IST), post the announcement of financial results for the quarter and nine months period ended 31 December 2024. Details for joining the call are attached.
The above information is a part of company’s filings submitted to BSE.